FDA Inspection 1022919 — Neomend Inc
The FDA completed an inspection of Neomend Inc on August 10, 2017 in Irvine, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 10, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Irvine, CA (United States)
Additional Details
Postmarket Audit Inspections